Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
NRSN NeuroSense Therapeutics
- 1.030
- -0.008-0.75%
Close May 2 16:00 ET
- 1.030
- 0.0000.00%
Post 20:01 ET
24.71MMarket Cap-1.91P/E (TTM)
1.030High0.990Low90.92KVolume1.020Open1.038Pre Close91.45KTurnover0.76%Turnover RatioLossP/E (Static)23.99MShares1.50052wk High9.54P/B12.28MFloat Cap0.51252wk Low--Dividend TTM11.93MShs Float8.180Historical High--Div YieldTTM3.85%Amplitude0.400Historical Low1.005Avg Price1Lot Size
NeuroSense Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | -21.32%-10.14M | -9.69%-8.35M | -394.87%-7.62M | -121.44%-1.54M | -19.42%-695K | -582K |
| Net income from continuing operations | -1.02%-10.21M | 3.67%-10.11M | -159.64%-10.49M | -42.89%-4.04M | -131.42%-2.83M | ---1.22M |
| Operating gains losses | 97.90%-46K | ---2.19M | ---- | ---2.72M | ---- | ---- |
| Depreciation and amortization | 4.76%22K | 75.00%21K | 300.00%12K | 0.00%3K | --3K | ---- |
| Other non cash items | -31.71%323K | 1,053.66%473K | -94.82%41K | 39,650.00%791K | ---2K | ---- |
| Change In working capital | -140.83%-781K | 74.70%1.91M | 301.10%1.1M | 284.51%273K | 144.83%71K | --29K |
| -Change in receivables | ---- | ---- | ---- | -1,600.00%-204K | -300.00%-12K | ---3K |
| -Change in payables and accrued expense | -101.96%-37K | 77.37%1.89M | 123.27%1.07M | 474.70%477K | 159.38%83K | --32K |
| -Change in other current assets | -825.81%-675K | -25.60%93K | --125K | ---- | ---- | ---- |
| -Change in other current liabilities | 0.00%-69K | 27.37%-69K | ---95K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | -21.32%-10.14M | -9.69%-8.35M | -394.87%-7.62M | -121.44%-1.54M | -19.42%-695K | ---582K |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -99.97%1K | 196.60%3.47M | -21,017.65%-3.59M | -88.89%-17K | 65.38%-9K | -26K |
| Net PPE purchase and sale | 89.66%-3K | 58.57%-29K | -311.76%-70K | -88.89%-17K | -28.57%-9K | ---7K |
| Net investment purchase and sale | --0 | 200.00%3.5M | ---3.5M | --0 | --0 | ---- |
| Net other investing changes | 233.33%4K | 85.00%-3K | ---20K | ---- | ---- | ---19K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -99.97%1K | 196.60%3.47M | -21,017.65%-3.59M | -88.89%-17K | 65.38%-9K | ---26K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 174.54%10.91M | 5.33%3.98M | -68.29%3.77M | 2,242.91%11.9M | -64.15%508K | 1.42M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | --0 | ---3K |
| Net common stock issuance | 160.82%11.3M | --4.33M | --0 | 1,841.73%9.86M | -64.23%508K | --1.42M |
| Proceeds from stock option exercised by employees | --0 | -99.87%5K | 204.85%3.77M | --1.24M | --0 | --0 |
| Net other financing activities | -7.42%-391K | ---364K | ---- | --800K | ---- | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 174.54%10.91M | 5.33%3.98M | -68.29%3.77M | 2,242.91%11.9M | -64.15%508K | --1.42M |
| Net cash flow | ||||||
| Beginning cash position | -25.49%2.64M | -67.97%3.54M | 1,482.69%11.06M | -21.90%699K | 940.70%895K | --86K |
| Current changes in cash | 185.51%779K | 87.74%-911K | -171.83%-7.43M | 5,378.57%10.35M | -124.23%-196K | --809K |
| Effect of exchange rate changes | -612.50%-41K | 109.09%8K | -588.89%-88K | --18K | --0 | --0 |
| End cash Position | 27.95%3.38M | -25.49%2.64M | -67.97%3.54M | 1,482.69%11.06M | -21.90%699K | --895K |
| Free cash flow | -20.94%-10.14M | -9.07%-8.38M | -393.96%-7.69M | -121.02%-1.56M | -19.52%-704K | ---589K |
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now